AstraZeneca Announces Positive Results From Interim Analysis Of DUO-O Phase III Trial
LONDON (dpa-AFX) - AstraZeneca PLC (AZN.L, AZN) announced positive results from interim analysis of DUO-O Phase III trial showed that…
78,979$
0,51%
Echtzeit-Aktienkurs Astrazeneca PLC (Spons. ADRs)
Bid:
Ask:
Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie
FDA Expands AstraZeneca (AZN) Lynparza Label in Prostate Cancer
Following FDAs label-expansion approval, AstraZenecas (AZN)/Mercks (MRK) Lynparza is the first PARP inhibitor approved in combination with a new hormonal…
Top Research Reports for Exxon Mobil, AstraZeneca & Netflix
Todays Research Daily features new research reports on 16 major stocks, including Exxon Mobil Corporation (XOM), AstraZeneca PLC (AZN) and…
AstraZeneca sees positive results for Imfinzi in gastric cancers
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca Says Imfinzi Data Shows Improved Response in Gastric Cancers
AstraZeneca Says Imfinzi Data Shows Improved Response in Gastric Cancers...…
Form 6-K ASTRAZENECA PLC For: Jun 02
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Imfinzi improved pCR in gastric and GEJ cancers
2 June 2023
Imfinzi plus chemotherapy significantly improved pathologic complete response in gastric and gastroesophageal junction cancers in MATTERHORN Phase III trial
First global…
Fact Check-É falso que Fiocruz parou de produzir vacina contra Covid-19 da AstraZeneca
...Por Reuters Fact Check
1…
AstraZeneca halts bowel disease drug program
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca and OMP Present the Journey Toward the Power of Decision Intelligence at Gartner Supply Chain Symposium/Xpo in Barcelona
BARCELONA, SPAIN / ACCESSWIRE / June 1, 2023 / OMP, a leading provider of supply chain planning solutions, invites attendees…
Form 6-K ASTRAZENECA PLC For: Jun 01
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca (AZN) Discontinues Brazikumab Development
AstraZeneca (AZN) announces its decision to discontinue the development of brazikumab for all indications under its inflammatory bowel disease program....…
AstraZeneca halts AbbVie-partnered bowel disease drug program
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca Announces Discontinuation Of IBD Development Programme For Brazikumab
LONDON (dpa-AFX) - AstraZeneca PLC (AZN.L, AZN) announced the discontinuation of the brazikumab inflammatory bowel disease development programme, being investigated…
TOP NEWS: AstraZeneca discontinues brazikumab; Lynparza wins approval
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca drug combo gets US nod to treat a type of prostate cancer
...(Reuters) - AstraZeneca said on Thursday that a combination......…
AstraZeneca Discontinues Brazikumab Inflammatory Bowel Disease Development Program
AstraZeneca Discontinues Brazikumab Inflammatory Bowel Disease Development Program...…
AstraZeneca to stop brazikumab inflammatory bowel disease programme
...June 1 (Reuters) - British drugmaker AstraZeneca
said on Thursday......…
AstraZeneca Says US Approved Lynparza as a Prostate Cancer Treatment
AstraZeneca Says US Approved Lynparza as a Prostate Cancer Treatment...…
BRIEF-Astrazeneca: Lynparza Approved In US For BRCam Prostate Cancer
...June 1 (Reuters) - AstraZeneca PLC:
* ASTRAZENECA PLC - LYNPARZA......…
BioLight Inks Agreement With Alexion To Explore Technology For Diagnosis Of Retinal Diseases
LONDON (dpa-AFX) - BioLight Life Sciences Ltd. announced Tuesday it has signed a research collaboration agreement with Alexion Pharmaceuticals, Inc.…
BioLight announces a joint cooperation agreement with Alexion (AstraZeneca Rare Disease) to explore an innovative technology based on natural tears for the diagnosis of retinal diseases
TEL AVIV, Israel, May 30, 2023 /PRNewswire/ -- BioLight (TASE: BOLT) is proud to report it has signed a research…
AstraZeneca (AZN) Drug Combo Meets Endometrial Cancer Study Goal
AstraZeneca (AZN) reports statistically significant results from a late-stage study evaluating the combination of Imfinzi and Lynparza in patients with…
BioStock: Prominent role for CombiGene in newly established national ATMP collaboration
The CEO of gene therapy company CombiGene, Jan Nilsson, has been appointed Chairman of CCRM Nordic, Centre for Commercialization of…
AstraZeneca announces good results from endometrial cancer trial
A greater clinical benefit was noted when Imfinzi and Lynparza were part of a combined treatment rather than when the…
AstraZeneca Imfinzi, Lynparza cuts risk of uterus cancer progression in phase 3 trial
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca Ultomiris gets approval in Japan for expanded use in rare nervous system disorder
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca hails the findings from cancer combination trial
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca Reports Positive Results From DUO-E Phase III Trial
LONDON (dpa-AFX) - AstraZeneca PLC (AZN.L, AZN) said positive high-level results from the DUO-E Phase III trial showed Imfinzi in…
BUSINESS LIVE: Retail sales bounce; Brickability CEO to step down
Among the companies with reports and trading updates today are Brickability, Revolution Beauty and AstraZeneca....…
AstraZeneca says drug combo shows positive results in late-stage endometrial cancer trial
...May 26 (Reuters) - AstraZeneca said on Friday a
combination of its......…
Form 6-K ASTRAZENECA PLC For: May 22
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
IN BRIEF: AstraZeneca hires LSEG CFO Anna Manz as non-exec director
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
BRIEF-Astrazeneca Says Anna Manz Appointed As Non-Executive Director
...May 22 (Reuters) - AstraZeneca PLC:
* ASTRAZENECA PLC - DIRECTORATE......…
Directorate Change
22 May 2023 07:05 BST
Non-Executive Board Appointment
AstraZeneca PLC announced today that Anna Manz has been appointed as a Non-Executive Director…
Why Astrazeneca (AZN) is a Great Dividend Stock Right Now
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…
UPDATE 1-AstraZeneca will seek to "love the Communist Party" - China boss
... and Brenda Goh
BEIJING, May 19 (Reuters) - Global drugmaker AstraZeneca... across a screen behind
him.
In response to questions from Reuters......…
AstraZeneca Neutral
ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Astrazeneca auf "Neutral" mit einem Kursziel von 12500…
Revvity licenses gene editing tech to AstraZeneca for cancer, immune-mediated therapies
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 6-K ASTRAZENECA PLC For: May 17
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca Tagrisso chemo combo cuts risk of lung cancer progression in trial
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca reports positive results in latest lung cancer trials
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca Reports Positive Trial Results Of Tagrisso Plus Chemotherapy In FLAURA2 Phase III Trial
LONDON (dpa-AFX) - AstraZeneca PLC (AZN.L, AZN) announced Wednesday positive high-level results from the FLAURA2 Phase III trial of Tagrisso…
AstraZeneca Tagrisso Drug In Combination With Chemo Showed Strong Improvement In Trial
AstraZeneca Tagrisso Drug In Combination With Chemo Showed Strong Improvement In Trial...…
AstraZeneca to exit leading U.S. drug industry group PhRMA
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca to leave leading U.S. drug lobby group
...By Maggie Fick
LONDON, May 16 (Reuters) - AstraZeneca has
decided......…
Is AstraZeneca Stock a Buy for Growth Investors?
This drugmaker is among the largest international players in the world....…
Pharma Stock Roundup: BAYRY Mixed Q1 Results, AZN, RHHBY Regulatory/Pipeline Updates
Bayer (BAYRY) announces mixed Q1 results. AstraZenecas (AZN) Ultomiris gets approval for a new rare disease indication in the EU....…
Total Voting Rights
1 December 2022 15:00 GMT
Transparency Directive
Voting rights and capital
The following notification is made in accordance with the UK Financial Conduct…
AstraZeneca Ultomiris gets expanded approval in EU for rare nervous system disorder
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…